Skip to content

Public FDA record

Z-1768-2022: ORCA FOAM STANDARD CUBE 10x10x10 mm, Absorbable Gelatin Sponge Hemostat, USP, REF ORCA FOAM

Recall record Z-1768-2022 for GELITA MEDICAL GMBH. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1768-2022
Company in FDA record
GELITA MEDICAL GMBH
FDA record creation date
Sep 19, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

In routine bioburden testing, higher than acceptable levels of Endotoxins were observed.

Source facts

Action
The firm emailed a Field Safety Notice to the sole consignee, a distributor, on 07/27/2022, 08/11/2022 and 08/15/2022. The first letter explained the problem, hazard, and requested the return of the product. If the product was further distributed to notify customers. The second and third letters requested that the recalled articles be destroyed.
Initiated
2022-07-27
Root cause
Under Investigation by firm
Terminated
2026-09-22
Distribution
US Nationwide distribution in the state of Alabama.
Recall number
Z-1768-2022
Recall status
Terminated
CDRH record ID
195618
FDA record created
2022-09-19
Recall event number
90743

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗